Stockscreener 앱 받기
3.93
8.39%
-0.36
시간 외 거래:
3.87
-0.06
-1.53%
전일 마감가:
$4.29
열려 있는:
$4.29
하루 거래량:
120.36K
Relative Volume:
5.69
시가총액:
$181.15M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.51%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$3.85
$4.29
1주일 범위
$3.85
$4.34
52주 변동 폭
$3.81
$4.8816
Capsovision Inc Stock (CV) Company Profile
CV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
3.93 | 196.12M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-28 | 개시 | Roth Capital | Buy |
| 2025-07-28 | 개시 | The Benchmark Company | Speculative Buy |
Capsovision Inc 주식(CV)의 최신 뉴스
CapsoVision, Inc.'s Quiet Period Set To Expire on August 11th (NASDAQ:CV) - MarketBeat
CapsoVision, Inc.’s (NASDAQ:CV) Quiet Period Will End on August 11th - Defense World
Is capsovision scam - AInvest
Roth Capital Predicts CapsoVision's Q2 Earnings (NASDAQ:CV) - MarketBeat
CapsoVision (NASDAQ:CV) Raised to Strong-Buy at Roth Capital - MarketBeat
CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025 - GlobeNewswire
Capsovision, Inc. shares fall 2.19% intraday as Kioxia Corporation announces new UFS 4.1 devices for automotive applications. - AInvest
Q2 Earnings Estimate for CapsoVision Issued By Roth Capital - Defense World
Roth Capital Upgrades CapsoVision (NASDAQ:CV) to Strong-Buy - Defense World
CapsoVision (NASDAQ:CV) Rating Increased to Strong-Buy at Roth Capital - Defense World
CapsoVision (NASDAQ:CV) Upgraded at Roth Capital - Defense World
CapsoVision (NASDAQ:CV) Upgraded by Roth Capital to Strong-Buy Rating - Defense World
CapsoVision (NASDAQ:CV) Raised to “Strong-Buy” at Roth Capital - Defense World
Capsovision, Inc. shares rise 3.45% intraday after Canon Inc. announces share buyback plan. - AInvest
CapsoVision is a buy, this analyst says - Cantech Letter
Capsovision, Inc. shares fall 1.15% premarket after Canon Inc. announced a buyback plan. - AInvest
CapsoVision (NASDAQ:CV) Now Covered by Benchmark - Defense World
CapsoVision (NASDAQ:CV) Earns Speculative Buy Rating from Analysts at Benchmark - MarketBeat
Benchmark Co. Initiates CapsoVision(CV.US) With Buy Rating, Announces Target Price $5 - 富途牛牛
CapsoVision: Benchmark initiates coverage with Speculative Buy rating, $5 price target. - AInvest
CapsoVision stock initiated with Speculative Buy rating at Benchmark By Investing.com - Investing.com India
Benchmark starts CapsoVision with a Speculative Buy as CapsoCam Plus takes share - TipRanks
CapsoVision initiated with a Buy at Roth Capital - TipRanks
CapsoVision stock initiated with Buy rating at Roth/MKM on GI imaging potential - Investing.com Nigeria
CapsoVision Completes $27.5 Million Nasdaq IPO - Global Legal Chronicle
CapsoVision enters development agreement with Canon and announces partial IPO overallotment exercise - Investing.com India
CapsoVision Raises $600,000 Through IPO Overallotment - TipRanks
Capsovision, Inc IPOs Tomorrow, Here's What You Need To Know - 富途牛牛
Capsovision, Inc. shares fall 2.66% after-hours following IPO close. - AInvest
CapsoVision prices $27.5M IPO - MSN
Capsovision, Inc. shares rise 5.25% intraday after closing $27.5 million IPO. - AInvest
Why Did CapsoVision Plunge 10.45% After IPO Pricing? - AInvest
CapsoVision's IPO: A Pill to Swallow in the GI Diagnostics Market? - AInvest
CapsoVision Soars 40.31% on IPO Debut - AInvest
CapsoVision Closes $27.5 Million IPO; Shares Rebound - MarketScreener
CapsoVision, Inc. Successfully Closes Initial Public Offering Raising $27.5 Million - Nasdaq
CapsoVision Announces Closing of Initial Public Offering - GlobeNewswire
CapsoVision Stocks: Bursting Bubbles or Rising Stars? - StocksToTrade
CapsoVision’s Wild Ride: Why This Med-Tech Newcomer Is Turning Heads on Nasdaq - RagingBull
CapsoVision’s Rollercoaster: Risk or Reward? - timothysykes.com
CapsoVision, Inc.(NasdaqCM: CV) added to NASDAQ Composite Index - MarketScreener
CapsoVision, Inc. Completes Successful IPO on Nasdaq - MSN
CapsoVision begins trading on Nasdaq at $5 per share, declines since - Investing.com India
CV IPO NewsMedical device maker CapsoVision prices IPO at $5, the low end of the range - renaissancecapital.com
CapsoVision Prices 5.5M Share IPO at $5/sh - Investing.com Australia
CapsoVision Prices IPO at $5 per Share - MarketScreener
Capsovision Announces Pricing Of Initial Public Offering - TradingView
Med-tech IPOs gain steam going into Q3 - BioWorld MedTech
CapsoVision Aims to Swallow GI Imaging Market – $28M Nasdaq Debut Eyes AI-Powered Diagnostic Future - Minichart
Capsovision Inc (CV) 재무 분석
Capsovision Inc (CV)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):